#6976 Re: Teorije zavjera, bre.... pa opletite
Posted: 20/02/2021 16:52
Porodica ne zeli obdukciju ali zato forumas iznad zna od cega je umro 
Porediš dvije sasvim različite stvari. Nije general Powell lagao o Sadamovom nepostojećem oružju na društvenim mrežama nego u generalnoj skupštini UN, ne sjećam se da su društvene mreže uopšte bili tako popularne kao danas.cvrčak_na_hedonizmu wrote: ↑20/02/2021 13:28Lokalne razmirice ? Bezocno se laze da Sadam ima neko strasno biolosko oruzje, direktno ubijes nekoliko miliona ljudi, indirektno jos toliko, onda pomognes da se stvori ISIL, krene sranje u Siriji gdje direktno pogine koji milion, indirektno i vise i na kraju imas valove izbjeglica koji idu u Europu. Zanimljive lokalne razmirice.Point. wrote: ↑20/02/2021 08:50Sve gore nabrojano su lokalne razmirice, ne uticu globalno kao ova pandemija. Ove konspiracije bez ikakvih dokaza oko pandemije, 5G mreze, vakcina, fol ukradenih izbora u USA sto narandzasti laze utice globalno i globalni je problem koji dotice vecinu planetarnog stanovnistva i postoji granica dokle se gluposti i lazi mogu tolerisati.cvrčak_na_hedonizmu wrote: ↑20/02/2021 02:55
Da, da. Manje su cenzurisali ISIL, al doslovno, od ovoga. Ili kada neko ubija ljude u Siriji, Iranu, Jemenu, Palestini, Libiji , Libanonu, Nagorno Karabahu i tako dalje onda taj argument ne vazi, jer koga je zapravo briga, a fact checkersi nisu rekli da to nije dobro.
Isto "princip" se primjenjuje u slucaju BLM pa su crni zivoti bitni u USA, fol, ali zato nisu u Africi.
Ima milion stranica, ali 95% stanovnistva prati gore navedene. Probaj se baviti marketingom, politikom, estradom, bla, bla i koristi te ostale stranice, nece sira familija znati za tebe.
Nije to bas tako kao sto kazes, samo se slazes sa desavanjima odnosno da to nesto treba cenzurisati pa nije problem, sto je naravno pogresno.
Opasan presedan se desio odnosno desava se, gdje su socijalne mreze pocele da odredjuju sta je istina, a sta nije. Al hajde, teska tema, stash se zamarat' sa trivijalnostima.
Mislim da nema efekta nastavljati, jer tebe to ocito ne zanima, nit' hoces da razumijes. Trosimo kalorije bezveze, realno.
Ps. Sve je teorija zavjere dok se ne dokaze suprotno, sto je normalno, problem nastupa sto kada teorija predje u cinjenicu ne desi se apsolutno nista. Cini mi se da je paznja ljudi, generalno, ogranicena na nekoliko sati ili dana. Poslije toga, bez medija, nista ne postoji, nit koga zanima. Zanimljiv fenomen.
‘IMAM DOKAZE!’; Njemački znanstvenik demantira WHO: ‘Siguran sam 99,9 posto da je virus pobjegao iz laboratorija’
https://net.hr/danas/svijet/imam-dokaze ... -u-wuhanu/
Bild: „Cijepite se, kancelarko!“
https://www.dw.com/bs/bild-cijepite-se- ... a-56612594
Nijemci nisu baš pohrlili na cijepljenje kao što se prvotno očekivalo, piše u svom današnjem izdanju najčitaniji njemački list Bild. Posebni problem predstavlja cjepivo proizvođača AstraZeneca u koje građani očito nemaju preveliko povjerenje. Kako izvještava Bild, do sada je iskorišteno samo 11 posto raspoloživih doza. Tako je u saveznoj pokrajini Baden-Württenberg upotrijebljeno samo 309 od ukupno 100.800 doza, a u Brandenburgu – nijedna.
Bild smatra da bi građane na cijepljenje svojim primjerom trebala potaknuti kancelarka Angela Merkel. No ona je izjavila: „Cijepit ću se kad na mene dođe red." I od toga ne odstupa. Kako navodi njemački list, mnogi političari i stručnjaci smatraju da griješi.
možete kasnije ojačati imunitetNjemački ministar: Cijepljeni AstraZenecom mogu kasnije dobiti drugo cjepivo
https://hr.n1info.com/znanost/njemacki- ... o-cjepivo/
“Bez ikakvih problema možete kasnije ojačati imunitet, potaknut cjepivom AstraZenece, cjepivom koje počiva na glasničkoj RNK.”
Balašević je preminuo od teške upale pluća sa 68 godina, ubrzo nakon što je primio prvu dozu cjepiva protiv COVIDA
https://dokumentarac.hr/cijepljenje/cla ... j0rk6nVe30
Nazalost jos nisu izumili vakcinu protiv zla, inace bi njega prvog cijepili.
https://balkans.aljazeera.net/news/worl ... trudnicama
Pfizer i BioNTech testiraju vakcinu protiv COVID-a na trudnicama

Professor Giuseppe Tritto, an internationally renowned expert in biotechnology and nanotechnology in his book ′′ China's COVID 19: The Chimera that changed the world ′′ said he believes that the Chinese Communist Party (CCP) stood behind the Wuhan Coronavirus (COVID-19), leaving little doubt that this viral ′′ chimera ′′ was artificially created as a bio weapon.
Earlier today - we spoke with professor Tritto, he says China has the ability to modify viruses - and develop bio weapons that - the Wuhan Virology Institute - did not follow global safety standards for a long time and - Chinese scientists specifically worked on bats coronaviruses - a project that Supervised by top military scientist She Zheng-lee.
Professor Tritto asks serious questions about the Wuhan laboratory, which is called the largest Asian scientific bank of the virus, classifies it as a ′′ P-4 ′′ object.

Ko da gledam bice lagano ignorisana zvanicna statistika koja pokazuje da je smrtnost u tri kvartala ista u doba corone i sezonu pre nje. U kojem momentu ce ovi corona svedoci staviti prst na celo i zapitati se da li je u redu sve ovo sto vlasti rade?
UŽIVO Alarmantno i vanredno; Moguće zatvaranje na pet dana?; "Ponoviće nam se decembar"
Beograd -- Pogoršava se epidemiološka situacija u Srbiji. Broj novoobolelih raste. Bolnički kapaciteti postaju ponovo prenatrpani, a lekari kažu da su na izmaku snaga.[/b]
https://www.b92.net/info/vesti/index.ph ... id=1816796[/u]
Hoce to kad su jutarnji.hr, b92.net itd. mjesta gdje kupis informacije. Jos si i dobar sta sve citas, mozak ti je otupio od clickbait naslova.Lao Ce wrote: ↑24/02/2021 14:00 Corona botovi i šišmiš believers, primjećujete li lažni pattern koji se ponavlja. Ovaca očigledno ima i dalje. Blejanje odjekuje kod jednog dijela forumaša![]()
UŽIVO Alarmantno i vanredno; Moguće zatvaranje na pet dana?; "Ponoviće nam se decembar"
Beograd -- Pogoršava se epidemiološka situacija u Srbiji. Broj novoobolelih raste. Bolnički kapaciteti postaju ponovo prenatrpani, a lekari kažu da su na izmaku snaga.
https://www.b92.net/info/vesti/index.ph ... id=1816796





Pfizer and BioNTech’s Covid-19 vaccine performed as well in the real world as it did in the clinical trial that led to its use, a large study conducted in Israel concluded.
The study, published Wednesday in the New England Journal of Medicine, is the largest to date assessing the effectiveness of the vaccine, comparing all illness, severe illness, and hospitalizations as well as deaths between 600,000 pairs of vaccinated and unvaccinated people.
That a vaccine will perform as well in the real world as it does in the highly controlled setting of a clinical trial is not a given, noted senior author Ran Balicer, director of the Clalit Research Institute of Israel.
“The vaccine fulfilled the promise that was there. And it was somewhat of a surprise to see that in a real-world setting, a vaccine was able to perform as well as it did in the very controlled setting of a clinical trial, where cold-chain is perfect and the people are being carefully selected,” said Balicer, who also chairs an expert panel that advises the Israeli government on the pandemic.
But he warned that while the vaccine performed very well — it was 94% protective against symptomatic Covid, across all age groups, even older adults — some fully vaccinated people did develop severe illness and some died. During the period of the study, nine people who were fully vaccinated died from Covid-19, compared to 32 people who had not yet been vaccinated.
“These vaccines are not a force field around you that negates the chance that you will have an illness or that you will have a severe illness,” Balicer said, noting that while two doses of the vaccine offer substantial protection against severe Covid infection and death, “there is residual risk.”
“And so I think continuing precautions, especially among those populations at risk … at a time when community spread is evident and is massive, as in the case in Israel, would be the prudent thing to do, even for those who are fully vaccinated,” he said.
Kathleen Neuzil, director of the Center for Vaccine Development at the University of Maryland School of Medicine, found the results of the study encouraging.
“This was a well-done study, and the findings support an impact of the vaccine on multiple important outcomes — any infection, symptomatic infection, hospitalizations and deaths,” she said. “The rapidity with which we are seeing impact after introduction of the SARS-CoV-2 vaccines … provides hope that with enough vaccine supply, we can get this pandemic under control.”
The authors of the study, from several institutions in Israel as well as Harvard School of Public Health and Boston Children’s Hospital, reported some data that will likely play into the ongoing debate about whether it would be safe to delay the second dose of the Pfizer vaccine to give a first dose more quickly to more people.
The Pfizer vaccine is a two-dose vaccine that is meant to be given 21 days apart. Health authorities in Britain have already decided to delay giving the second dose, and some experts in the United States are pushing for this country to follow suit. But to date the Food and Drug Administration has resisted the calls to change the dosing schedule for the virus.
Almost everyone in Israel who got the vaccine received their second dose on time, so that study cannot answer the question of how well the protection induced by the first dose of vaccine would last if it was not boosted at the appropriate time.
But the analysis showed that from day 14 after the first shot — the point at which protection is seen to start to take effect — to day 20, the day before the second dose, there was moderate protection against any infection but better protection against serious disease.
During that narrow window of time, protection against documented Covid infection after one dose was 46% — below the FDA’s stipulated cut off of 50% efficacy. But for symptomatic infection, hospitalization, and severe illness, the protection for that period was 57%, 74%, and 62% respectively.
The authors estimated that one dose of vaccine was 72% protective against death from Covid in that seven-day period, though because of the numbers of deaths was small, it’s difficult to draw firm conclusions.
The study also found the vaccine worked well in people with significant health problems — another real-world test that vaccines don’t always pass with flying colors.
Noa Dagan, an author also from the Clalit Research Institute, said that for people with one or two health conditions that increased their risk of severe Covid illness, the vaccine worked as well as it did for people who were healthy.
Even in people with three or more health conditions, the vaccine’s protection appeared to be strong, with about 89% effectiveness, she said.
As Covid vaccines start to be used more broadly, there will be a multitude of studies looking at how well the vaccines work and whether some work better in certain segments of the population than others. Such data are badly needed as the world tries to figure out how best to use vaccines that will be in scarce supply for months or longer.
“I think the results are useful, in that we can start to leverage large observational datasets to fill in gaps in our understanding, primarily by enabling finer breakdowns by age, comorbidity, and time since vaccination, as they have done here,” said Natalie Dean, a biostatistician at the University of Florida.